Press Releases

LabStyle Innovations Corp. (Nasdaq: DRIO) to Ring The Nasdaq Stock Market Closing Bell

Globe Newswire
Mar 23, 2016

ADVISORY, March 23, 2016 (GLOBE NEWSWIRE) -- 

LabStyle Innovations Corp. (Nasdaq:DRIO), developer of the Dario™ Blood Glucose Monitoring System, will visit the Nasdaq MarketSite in Times Square, in celebration of its recent uplisting and the launch of the Dario in the U.S..

In honor of the occasion, Erez Raphael, Chairman and Chief Executive Officer will ring the Closing Bell. 

Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

Thursday, March 24, 2016 – 3:45 p.m. to 4:00 p.m. ET   

LabStyle Innovations Media Contact:
Yael Ayalon
+972 54 947 4380 

Nasdaq MarketSite:
Emily Pan
(646) 441-5120

Feed Information:
Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0

Social Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:

For photos from ceremonies and events visit our Instagram Page:

For livestream of ceremonies and events visit our YouTube Page:

For news tweets, please visit our Twitter page at:

For exciting viral content and ceremony photos visit our Tumblr Page:

A LiveStream of the Nasdaq Closing Bell will be available at: or

To obtain a hi-resolution photograph of the Market Close, please go to and click on the market close of your choice.

About the Dario
The Dario Blood Glucose Monitoring System is intended for the quantitative measurement of glucose (sugar) in fresh capillary whole blood. The Dario is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home to monitor the effectiveness of diabetes control.

The Dario Blood Glucose Monitoring System consists of a device housing that includes a blood glucose meter and lancing device. The system also includes test strips, lancets, control solutions and a mobile application. The Dario meter does not require coding or separate batteries. The Dario meter is powered via the 3.5mm audio headphone jack of the smart mobile device. Users are instructed to insert the test strip into the meter, apply the blood or control solution to the test strip, after which the meter will process the test in approximately six (6) seconds and display the test result on the smart mobile device screen via the mobile application.

The Dario Blood Glucose Monitoring System uses Apple’s iOS smart mobile device technology to view the glucose test results via a mobile application. This application is available for download via the smart mobile device’s application store.

About LabStyle Innovations
LabStyle Innovations Corp. (NASDAQ:DRIO) creates innovative mobile and digital tools that empower and engage users to lead healthier lives. LabStyle’s “Real time. Real improvements. Real People.” approach and strategy is positioning the company as a major player in the mHealth industry. LabStyle’s flagship product is the Dario™ Blood Glucose Monitoring System. Dario™ received U.S. FDA clearance in December 2015 and received Europe’s CE mark certification in September 2013.

For more information, the content of which is not part of this press release: and

About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.6 trillion and nearly 10,000 corporate clients. To learn more, visit: or


For further information: Contacts: Press and Investor Relations Brenda Zeitlin LabStyle Innovations +1-800-896-9062